Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

(2017) Anders Nyboe Andersen et al.   FERTILITY AND STERILITY

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder

(2017) Theodora C van Tilborg et al.   HUMAN REPRODUCTION

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder

(2017) Simone C Oudshoorn et al.   HUMAN REPRODUCTION

Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review

(2016) Theodora C. van Tilborg et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation

(2016) Nam D. Tran et al.   FERTILITY AND STERILITY

Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178 898 women

(2016) David J. McLernon et al.   HUMAN REPRODUCTION

Reporting multiple cycles in trials on medically assisted reproduction

(2016) Irma Scholten et al.   REPRODUCTIVE BIOMEDICINE ONLINE

450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial

(2015) Jessica Lefebvre et al.   FERTILITY AND STERILITY

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials

(2015) Scott M. Nelson et al.   FERTILITY AND STERILITY

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa

(2015) F. Olivennes et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response

(2014) Stamatina Iliodromiti et al.   HUMAN REPRODUCTION UPDATE

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

(2014) Simone L. Broer et al.   HUMAN REPRODUCTION UPDATE

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis

(2013) Simone L. Broer et al.   FERTILITY AND STERILITY

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

(2013) A. La Marca et al.   HUMAN REPRODUCTION UPDATE

The Impact of Depot GnRH Agonist on AMH Levels in Healthy Reproductive-Aged Women

(2013) H. Irene Su et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

(2012) Simone L. Broer et al.   HUMAN REPRODUCTION UPDATE

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

(2012) Theodora C van Tilborg et al.   BMC Womens Health

Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model

(2011) Lobke M. Moolenaar et al.   FERTILITY AND STERILITY

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles

(2011) Sesh Kamal Sunkara et al.   HUMAN REPRODUCTION

A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count

(2010) K Jayaprakasan et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

(2010) S. L. Broer et al.   HUMAN REPRODUCTION UPDATE

What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?

(2009) Murat Berkkanoglu et al.   FERTILITY AND STERILITY

The antral follicle count: practical recommendations for better standardization

(2009) Frank J.M. Broekmans et al.   FERTILITY AND STERILITY

A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial

(2009) Richard H. Reindollar et al.   FERTILITY AND STERILITY

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

(2009) A. La Marca et al.   HUMAN REPRODUCTION UPDATE

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

(2008) Simone L. Broer et al.   FERTILITY AND STERILITY

Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone

(2008) K. Jayaprakasan et al.   HUMAN REPRODUCTION

Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response

(2008) K. Jayaprakasan et al.   HUMAN REPRODUCTION